Provided by Tiger Trade Technology Pte. Ltd.

Illumina

119.32
+2.071.77%
Post-market: 119.20-0.1200-0.10%17:56 EST
Volume:2.48M
Turnover:295.49M
Market Cap:18.23B
PE:21.89
High:119.92
Open:117.50
Low:115.21
Close:117.25
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.82
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.48%
PB:6.70
PE(LYR):21.89

Loading ...

Illumina Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Yesterday

Illumina Earnings Call Highlights Clinical Growth Momentum

TIPRANKS
·
Feb 07

Illumina Is Maintained at Neutral by JP Morgan

Dow Jones
·
Feb 07

Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Ocular Therapeutix (OCUL)

TIPRANKS
·
Feb 07

Illumina Down Over 9%, on Pace for Largest percent Decrease Since May 2022 -- Data Talk

Dow Jones
·
Feb 07

UBS Adjusts Illumina Price Target to $135 From $120, Maintains Neutral Rating

MT Newswires Live
·
Feb 06

Stock Track | Illumina Plummets 9.09% Intraday on Mixed 2026 Guidance and JP Morgan Price Target Cut

Stock Track
·
Feb 06

Shares of Illumina Down 6.8% After Q4 Results

THOMSON REUTERS
·
Feb 06

Illumina price target raised to $135 from $120 at UBS

TIPRANKS
·
Feb 06

Guggenheim Reaffirms Their Buy Rating on Illumina (ILMN)

TIPRANKS
·
Feb 06

Illumina (ILMN) Receives a Hold from Canaccord Genuity

TIPRANKS
·
Feb 06

Shares of Illumina Down 5.9% Premarket After Q4 Results

THOMSON REUTERS
·
Feb 06

Illumina (ILMN) Gets a Sell from Barclays

TIPRANKS
·
Feb 06

Stock Track | Illumina Plunges 8.47% in Pre-Market on Mixed Earnings Outlook and JP Morgan Target Price Cut

Stock Track
·
Feb 06

Stock Track | Illumina Plunges 8.13% in Post-Market on Mixed Earnings Outlook

Stock Track
·
Feb 06

Illumina Posts Higher 4Q Profit, Revenue

Dow Jones
·
Feb 06

Standard BioTools Amends Financials After SomaLogic Sale to Illumina

Reuters
·
Feb 06

Stock Track | Illumina Plunges 5.7% After-Hours on Mixed Earnings Outlook

Stock Track
·
Feb 06

Illumina reports Q4 adjusted EPS $1.35, consensus $1.23

TIPRANKS
·
Feb 06

Illumina sees FY26 adjusted EPS $5.05-$5.20, consensus $5.07

TIPRANKS
·
Feb 06